Literature DB >> 20514030

Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead.

Kazim H Narsinh1, Joseph C Wu.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20514030      PMCID： PMC2889735          DOI： 10.1038/mt.2010.92

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  22 in total

1.  Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus.

Authors:  C Deng; M R Capecchi
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

2.  Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery.

Authors:  Angelo Lombardo; Pietro Genovese; Christian M Beausejour; Silvia Colleoni; Ya-Li Lee; Kenneth A Kim; Dale Ando; Fyodor D Urnov; Cesare Galli; Philip D Gregory; Michael C Holmes; Luigi Naldini
Journal:  Nat Biotechnol       Date:  2007-10-28       Impact factor: 54.908

3.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

Authors:  Iram F Khan; Roli K Hirata; Pei-Rong Wang; Yi Li; Jordan Kho; Angel Nelson; Yunwen Huo; Maja Zavaljevski; Carol Ware; David W Russell
Journal:  Mol Ther       Date:  2010-04-20       Impact factor: 11.454

6.  Homologous recombination in human embryonic stem cells.

Authors:  Thomas P Zwaka; James A Thomson
Journal:  Nat Biotechnol       Date:  2003-02-10       Impact factor: 54.908

7.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

8.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

9.  Identification and targeting of the ROSA26 locus in human embryonic stem cells.

Authors:  Stefan Irion; Hervé Luche; Paul Gadue; Hans Joerg Fehling; Marion Kennedy; Gordon Keller
Journal:  Nat Biotechnol       Date:  2007-11-25       Impact factor: 54.908

10.  AAV vector integration sites in mouse hepatocellular carcinoma.

Authors:  Anthony Donsante; Daniel G Miller; Yi Li; Carole Vogler; Elizabeth M Brunt; David W Russell; Mark S Sands
Journal:  Science       Date:  2007-07-27       Impact factor: 47.728
View more
  12 in total

Review 1.  Targeted gene therapies: tools, applications, optimization.

Authors:  Olivier Humbert; Luther Davis; Nancy Maizels
Journal:  Crit Rev Biochem Mol Biol       Date:  2012 May-Jun       Impact factor: 8.250

2.  Modeling neurological diseases using patient-derived induced pluripotent stem cells.

Authors:  Tarja A Juopperi; Hongjun Song; Guo-Li Ming
Journal:  Future Neurol       Date:  2011-05

3.  Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction.

Authors:  Guan-Yu Chen; Shiaw-Min Hwang; Hung-Ju Su; Chien-Yi Kuo; Wen-Yi Luo; Kai-Wei Lo; Cheng-Chieh Huang; Chiu-Ling Chen; Sheng-Han Yu; Yu-Chen Hu
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  A comparison of pluripotency and differentiation status of four mesenchymal adult stem cells.

Authors:  Fatemeh Jamshidi Adegani; Lida Langroudi; Ehsan Arefian; Abbas Shafiee; Peyman Dinarvand; Masoud Soleimani
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316

5.  In vitro gene manipulation of spinal muscular atrophy fibroblast cell line using gene-targeting fragment for restoration of SMN protein expression.

Authors:  A Rashnonejad; C Gündüz; S Y Süslüer; H Onay; B Durmaz; M Bandehpour; F Özkınay
Journal:  Gene Ther       Date:  2015-09-02       Impact factor: 5.250

6.  Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.

Authors:  Justin Lowenthal; Scott Lipnick; Mahendra Rao; Sara Chandros Hull
Journal:  Stem Cells Transl Med       Date:  2012-05-08       Impact factor: 6.940

Review 7.  Primary skin fibroblasts as a model of Parkinson's disease.

Authors:  Georg Auburger; Michael Klinkenberg; Jessica Drost; Katrin Marcus; Blas Morales-Gordo; Wolfram S Kunz; Ulrich Brandt; Vania Broccoli; Heinz Reichmann; Suzana Gispert; Marina Jendrach
Journal:  Mol Neurobiol       Date:  2012-02-19       Impact factor: 5.590

8.  Stem cell aging in adult progeria.

Authors:  Hoi-Hung Cheung; Duanqing Pei; Wai-Yee Chan
Journal:  Cell Regen (Lond)       Date:  2015-10-03

9.  Robust method for TALEN-edited correction of pF508del in patient-specific induced pluripotent stem cells.

Authors:  María Vicenta Camarasa; Víctor Miguel Gálvez
Journal:  Stem Cell Res Ther       Date:  2016-02-09       Impact factor: 6.832

10.  Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy.

Authors:  Gaetano Romano
Journal:  ISRN Oncol       Date:  2012-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.